Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joshua J. Hon has a total of 85 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multivessel Versus Single-Vessel Coronary Endarterectomy as an Adjunct to Coronary Artery Bypass Grafting: A Meta-Analysis of Short-Term Outcomes and Implications for Target-Vessel Selection

    by Joshua J Hon, Arian Arjomandi Rad, Abdullah Tahir, Elisa Salagean, Marco Moscarelli, Dimitrios E Magouliotis, Roberto Casula, Thanos Athanasiou

    Objectives: Coronary endarterectomy (CE) extends complete revascularization to patients with diffuse coronary disease unsuitable for conventional bypass but adds perioperative risk to coronary artery bypass grafting (CABG). Whether the number of vessels endarterectomized influences early outcomes has not been formally synthesized. We compared short-term outcomes of single-vessel and multivessel CE-CABG. Methods: MEDLINE, Embase, and CENTRAL were searched for studies of CE-CABG reporting outcomes stratified by single-vessel vs multivessel CE within the same cohort. The primary outcome was 30-day or in-hospital mortality. Risk ratios (RR) were pooled using DerSimonian–Laird random-effects models. Sensitivity analyses included leave-one-out analysis, Hartung–Knapp–Sidik–Jonkman (HKSJ) adjustment, and univariate meta-regression on study-level covariates. Risk of bias was assessed with ROBINS-I. Results: Nine studies (1988-2022; 7302 patients; 4731 single-vessel CE, 2571 multivessel CE) met inclusion criteria. Multivessel CE was associated with higher mortality (RR, 2.59; 95% CI, 1.78-3.77), higher perioperative myocardial infarction (RR, 2.09; 95% CI, 1.67-2.62), and higher stroke (RR, 1.62; 95% CI, 1.01-2.61). Intra-aortic balloon pump use did not differ. Findings were stable on leave-one-out, HKSJ adjustment, and exclusion of pre-2000 studies. No single covariate accounted for the multivessel effect on meta-regression. Conclusions: Multivessel CE substantially increases early mortality and infarction relative to single-vessel CE. The signal is consistent across analyses but the evidence is largely retrospective and unadjusted. These data support a selective approach to CE in which the prognostic value of each target vessel is weighed against the cumulative operative cost, rather than routine extension of endarterectomy to multiple territories.

  • Open Access

    The Artificial Intelligence Ecosystem in Cardiac Surgery: Current Landscape and Emerging Directions

    by Joshua J. Hon, Hojjat Salehinejad, Juan A. Crestanello, Joseph A. Dearani, Arman Arghami

  • Comparative effectiveness of influenza vaccination dosing strategies for cardiovascular protection: A systematic review and network meta-analysis of randomized controlled trials

    by Joshua J. Hon, Tadao Aikawa, Tor Biering-Sørensen, Elliot Crouch, Masao Iwagami, Leandro Slipczuk, Alexandros Briasoulis, Jose Wiley, Kaveh Hosseini, Deepak L. Bhatt, et al.

  • Open Access

    Cryoballoon Versus Radiofrequency Ablation for Persistent Atrial Fibrillation: Meta‐Analysis of Randomized Trials

    by Harroop Bola, Aksaan Arif, Joshua J. Hon, Gayathri Giritharan, Prachur Khandelwal, Rodrick Avakian, Amar Rai, Kiran Haresh Kumar Patel, Fu Siong Ng

    Introduction: Pulmonary vein isolation (PVI) alone achieves modest arrhythmia freedom in persistent atrial fibrillation (PeAF). Cryoballoon ablation (CBA) offers a single‐shot alternative to radiofrequency ablation (RFA) that streamlines procedural workflow. We aimed to quantify the clinical efficacy, procedural efficiency, and safety of CBA versus RFA through a meta‐analysis of randomized controlled trials (RCTs). Methods and Results: Systematic review of PubMed, Embase, and Scopus identified 5 RCTs enrolling 1,091 patients (515 CBA, 576 RFA). The primary endpoint was 12‐month freedom from any atrial arrhythmia, with isolated AF, and atrial tachycardia/flutter evaluated as secondary endpoints. Random‐effects models generated relative risks (RRs) and mean differences (MDs) with 95% confidence intervals (CI). Time‐to‐event data were pooled using a generic inverse‐variance approach to derive hazard ratios (HR). CBA and RFA demonstrated equivalent freedom from any arrhythmia (RR 0.97, 95% CI 0.81–1.15; p = 0.71). Time‐to‐event analysis corroborated a comparable recurrence hazard (HR 0.91, 95% CI 0.67–1.24; p = 0.56; I 2 = 0%). Repeat ablation rates were identical (RR 0.93; p = 0.50). CBA significantly reduced procedural time (MD −45.37 min; p < 0.0001), while major complications were comparable (1.5% vs. 2.7%; p = 0.18). Trial sequential analysis indicated that further randomization is unlikely to demonstrate superiority. Conclusion: In PeAF, CBA and RFA achieve equivalent 12‐month arrhythmia‐free survival and comparable repeat‐ablation rates, while CBA confers a highly significant reduction in procedural time. However, reliance on 12‐month follow‐up and heterogeneous rhythm surveillance protocols may limit assessments of true long‐term durability.

  • The Role of Artificial Intelligence in Surgical Safety

    by Arian Arjomandi Rad, Joshua J. Hon, Aws Al-Omari, Vasiliki Androutsopoulou, Prokopis-Andreas Zotos, Peyman Sardari Nia

  • Open Access

    Ethanol infusion of the vein of marshall-based strategies for persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials

    by Harroop Bola, Thalia Melamed, Mohamed Allaf, Joshua J Hon, Gayathri Giritharan, Amar Rai, Kiran Haresh Kumar Patel, Fu Siong Ng

    Aims: Pulmonary vein isolation (PVI) alone achieves modest arrhythmia freedom in persistent atrial fibrillation (PeAF). Ethanol infusion of the vein of Marshall (EIVOM) overcomes heat-sink effects, facilitating mitral isthmus (MI) block, and may represent an effective adjunctive ablation strategy. We aimed to quantify the efficacy and safety of EIVOM through a meta-analysis of randomized controlled trials (RCTs). Methods and results: Systematic review of MEDLINE, Web of Science, and PubMed identified 5 RCTs enrolling 1179 patients (602 EIVOM, 577 control). The primary endpoint was 12-month freedom from any atrial arrhythmia. Random-effects models generated risk ratios (RRs) with 95% confidence intervals (CI). Time-to-event data were pooled using a generic inverse-variance approach to derive hazard ratios (HR). EIVOM-based strategies improved freedom from any arrhythmia (RR 1.16, 95% CI 1.04–1.29; P < 0.001; number needed to treat (NNT) = 10) and from atrial fibrillation (RR 1.11, 95% CI 1.05–1.18; P < 0.001; NNT = 13). Time-to-event analysis demonstrated a sustained reduction in recurrence hazard (HR 0.72, 95% CI 0.64–0.81; P = 0.003; I2 = 0%). Repeat ablation was reduced (RR 0.61; P = 0.009). Fluoroscopy time increased (+9.08 min; P = 0.007), while major complications were comparable (2.5% vs. 2.8%; P = 0.47). Trial sequential analysis confirmed that the cumulative Z-curve crossed the monitoring boundary for benefit for the primary endpoint, indicating that the available evidence is sufficient. Conclusion: In PeAF, EIVOM-based ablation strategies significantly improve 12-month arrhythmia-free survival and reduce repeat procedures without increasing major adverse events. However, the observed benefit reflects composite ablation sets rather than ethanol infusion in isolation, and the predominance of high-volume expert centres may limit generalizability.


  • Open Access

    Short-Term Outcomes of Coronary Endarterectomy as an Adjunct to Coronary Artery Bypass Grafting: A Systematic Review and Meta-Analysis of Over 100 000 Patients

    by Joshua J Hon, Arian Arjomandi Rad, Archie Egrilmezer, Fadi Ibrahim Al-Zubaidi, Andrea D’ALessio, Shivika Sharma, Mariam Omar, Vasiliki Androutsopoulou, Sadeq Ali-Hasan-Al-Saegh, Alexander Weymann, et al.

    Objectives: To assess short-term outcomes of coronary artery bypass grafting (CABG) with adjunct coronary endarterectomy (CE) compared with isolated bypass grafting, and to synthesize available confounder-adjusted effect estimates. Methods: We conducted a systematic review and meta-analysis following PRISMA guidelines. MEDLINE, Embase, and CENTRAL were searched from January 2000 to June 2025. Eligible studies compared adult patients undergoing CABG with CE versus isolated CABG. Two reviewers independently screened studies, extracted data, and assessed quality. Random-effects meta-analysis was performed. The primary outcome was 30-day or in-hospital mortality. Results: Sixteen studies (119 458 patients) were included. CABG with CE was associated with higher mortality (RR 1.84, 95% CI 1.65-2.04). Pooling adjusted odds ratios from 3 studies yielded OR 1.76 (95% CI 1.55-2.00), with 2 of 3 individual estimates not reaching significance. Secondary outcomes showed increased risks of perioperative myocardial infarction (RR 1.99, 95% CI 1.29-3.07), stroke (RR 1.37, 95% CI 1.08-1.75), renal failure (RR 1.62, 95% CI 1.44-1.82), and intra-aortic balloon pump use (RR 1.96, 95% CI 1.41-2.70). Sensitivity analyses confirmed consistency across all the subgroups. Conclusions: CABG with CE is associated with higher short-term mortality and morbidity compared with isolated bypass grafting; however, confounder-adjusted analyses suggest this excess risk is partly attributable to greater baseline disease severity rather than an independent procedural effect. The scarcity of data and absence of randomized evidence preclude definitive causal conclusions. These findings provide benchmarking data for counselling when endarterectomy is necessary to achieve complete revascularization.

  • Socioeconomic disparities in glioma outcomes: a grade-specific analysis

    by Joshua J. Hon, Helena Akbarzadeh Mostaghbal, Yash Akkara, Joe M. Das


  • Open Access

    Clinical and Haemodynamic Outcomes in Small Versus Large Prostheses in Surgical Aortic Valve Replacement: A Systematic Review and Meta‐Analysis

    by Joshua J. Hon, Arian Arjomandi Rad, Odhran Harbinson, Fadi Al-Zubaidi, Peyman Sardari Nia, Rana Sayeed, Vivek Srivastava, Antonios Kourliouros, Thanos Athanasiou

    Objectives: This systematic review and meta‐analysis evaluate clinical and haemodynamic outcomes between small (≤ 21 mm) and large (≥ 23 mm) prosthetic valves in surgical aortic valve replacement (SAVR). Methods: A comprehensive literature search was conducted from inception to March 2025. Studies comparing outcomes between small and large aortic valve prostheses were included. Primary outcome was all‐cause mortality. Secondary outcomes included short‐term mortality, stroke, reoperation, endocarditis, haemodynamic parameters and patient‐prosthesis mismatch (PPM). Random‐effects models calculated pooled risk ratios (RRs) or mean differences (MDs). Mediation analysis explored the relationships between prosthesis size, PPM and mortality. Results: Twelve studies comprising 9896 patients were included. Small prostheses were associated with increased all‐cause mortality (RR 1.23, 95% CI 1.07–1.41, p = 0.004) and short‐term mortality (RR 1.73, 95% CI 1.11–2.68, p = 0.015). No significant differences were observed for stroke, reoperation or endocarditis. Small prostheses demonstrated significantly lower indexed effective orifice area (MD −0.13 cm 2 /m 2 , 95% CI ‐0.24 to −0.01, p = 0.030) and higher incidence of PPM (RR 2.02, 95% CI 1.36–3.00, p < 0.0001). Mediation analysis revealed a strong correlation ( r = 0.904) between PPM and all‐cause mortality effect sizes. Very small prostheses (< 19 mm) exhibited elevated mean gradients (20.8 mmHg) and substantial PPM incidence (33.2%). Conclusions: Small aortic valve prostheses are associated with increased mortality and PPM. The strong correlation between PPM and mortality effects suggests PPM may be the key mechanism underlying adverse outcomes. Alternative strategies such as root enlargement may be warranted in patients requiring small prostheses.